Investigative Toxicology and Toxicological Risk Assessments
Toxicology Model Development
Generate stand out datasets to exemplify and showcase your platform potential and differentiate your innovative technology from the competition. MedRow Scientific offer services to assist you in performing competitive landscape analysis, defining your scientific and commercial strategy and refining study plans to maximise your data impact.
New Approach Methodologies
Toxicology model selection
With the many exciting developments in New Approach Methodologies (NAMs) for organ specific toxicology, and clear movements towards regulatory acceptance, now is the time to integrate NAMs into your discovery workflows. MedRow Scientific can assist you in identifying useful models for your needs and help mange the integration of these models into your discovery pathway.
Medical Device Biocompatibilty
Investigative Toxicology Study Design
If your development studies identify an unexpected safety signal or preclinical toxicological event an experienced and European Registered Toxicologist can help tailor study designs and endpoints to address the identified biological risks of your medical device. Whether it is a non-GLP investigative study or extensions in your GLP ISO 10993 compliant studies with enhanced endpoints, MedRow Scientific can advise on studies to ensure your medical device biocompatibility studies fully address your identified risks.
Toxicological Risk Assessments
Chemical Characterisation of your Medical Device and Toxicological Risk Assessment of the results is central to the development of novel medical devices and materials. MedRow Scientific can advise on the design of extractables and leachables studies appropriate to your device, manage their execution and provide expert Toxicological Risk Assessment, in compliance with ISO 10993-17, of the data generated in the context of your product use case.
